There may be a dearth of new drugs on the horizon this year, but when a new drug is introduced to treat a class of disorders for which no new patent has been specifically developed in over 40 years — it is noteworthy. For as long as I have been alive, no new agent has been specifically developed to target the common disorder of the great toe known as gout. Say hello to Uloric.

Related Posts Within Doctor Pundit:

1. FDA Approves Drug from Genetically Engineered Goats The potential for an anticoagulant drug “harvested” from the milk...
2. Pharma Company Prepares to Revolutionize anti-TB Treatment with 2 Currently Used Antibiotics Recently this blog introduced its readers to a new drug...
3. Study: First Available Mega-Combination Cardiac Drug in Development Sometimes the fastest way from an NDA to market is...
4. Diabetes Drug Once Again under Scrutiny A couple of weeks before the FDA meets to discuss...
5. Pharma Company Strives to Keep Star Performing Drug Close Twenty-eleven and 2012 are going to be remembered in the...